Back to Results

An open-label, repeat-application, intra-subject, dose escalation (Part 1) followed by a randomized, double-blind, placebo-controlled (Part 2) trial of topical VT30 in subjects with venous, lymphatic or mixed malformations associated with PIK3CA or TEK genetic mutations

Study category: Heart and Blood Conditions

Is this Study for You?

Let's Get Started!


Child to Adult

Type of Study



Childrens Hospital Colorado

Principal Investigator
Taizo Nakano,  MD

Taizo Nakano, MD

Study ID

Protocol Number: 20-1757

More information available at NCT04409145

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers